{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:11:30Z","timestamp":1788768690741,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12015-026-11200-x","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:49:01Z","timestamp":1785203341000},"page":"3196-3208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cell Therapy as Metabolic Rescue after Ischemic Stroke: Rewiring Bioenergetics, Redox Homeostasis, and Neurovascular Repair"],"prefix":"10.1007","volume":"22","author":[{"given":"Salar","family":"Bakhtiyari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Alipourfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"11200_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","volume":"5","author":"BCV Campbell","year":"2019","unstructured":"Campbell, B. C. V., De Silva, D. A., Macleod, M. R., et al. (2019). Ischaemic stroke. Nat Rev Dis Primers, 5, 70.","journal-title":"Nat Rev Dis Primers"},{"key":"11200_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends In Neurosciences, 22, 391\u2013397.","journal-title":"Trends In Neurosciences"},{"key":"11200_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrn1106","volume":"4","author":"EH Lo","year":"2003","unstructured":"Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003). Mechanisms, challenges and opportunities in stroke. Nature Reviews Neuroscience, 4, 399\u2013415.","journal-title":"Nature Reviews Neuroscience"},{"key":"11200_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010). The science of stroke: mechanisms in search of treatments. Neuron, 67, 181\u2013198.","journal-title":"Neuron"},{"key":"11200_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","volume":"7","author":"C Qin","year":"2022","unstructured":"Qin, C., Yang, S., Chu, Y. H., et al. (2022). Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther, 7, 215.","journal-title":"Signal Transduct Target Ther"},{"key":"11200_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","volume":"15","author":"A Chamorro","year":"2016","unstructured":"Chamorro, A., Dirnagl, U., Urra, X., & Planas, A. M. (2016). Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurology, 15, 869\u2013881.","journal-title":"Lancet Neurology"},{"key":"11200_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1747-4949.2009.00387.x","volume":"4","author":"CL Allen","year":"2009","unstructured":"Allen, C. L., & Bayraktutan, U. (2009). Oxidative stress and its role in the pathogenesis of ischaemic stroke. International Journal Of Stroke : Official Journal Of The International Stroke Society, 4, 461\u2013470.","journal-title":"International Journal Of Stroke : Official Journal Of The International Stroke Society"},{"key":"11200_CR8","doi-asserted-by":"publisher","first-page":"721428","DOI":"10.3389\/fnagi.2021.721428","volume":"13","author":"X Zhou","year":"2021","unstructured":"Zhou, X., Li, R., Liu, X., et al. (2021). Mitochondrial dynamics: a potential therapeutic target for ischemic stroke. Frontiers In Aging Neuroscience, 13, 721428.","journal-title":"Frontiers In Aging Neuroscience"},{"key":"11200_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41419-025-08114-w","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Ge, M., Wang, J., Xu, Y., Wang, N., & Xu, S. (2025). Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm. Cell Death And Disease, 16, 788.","journal-title":"Cell Death And Disease"},{"key":"11200_CR10","doi-asserted-by":"publisher","first-page":"1514394","DOI":"10.3389\/fneur.2025.1514394","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu, Y., et al. (2025). The impact of glycolysis on ischemic stroke. Frontiers In Neurology, 16, 1514394.","journal-title":"Frontiers In Neurology"},{"key":"11200_CR11","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin, L., & Magistretti, P. J. (1994). Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A, 91, 10625\u201310629.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11200_CR12","doi-asserted-by":"crossref","unstructured":"Yamagata, K. (2022). Lactate supply from astrocytes to neurons and its role in ischemic stroke-induced neurodegeneration. Neuroscience, 15, 219\u2013231.","DOI":"10.1016\/j.neuroscience.2021.11.035"},{"key":"11200_CR13","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.7150\/thno.96375","volume":"14","author":"XY Xiong","year":"2024","unstructured":"Xiong, X. Y., Pan, X. R., Luo, X. X., et al. (2024). Astrocyte-derived lactate aggravates brain injury of ischemic stroke in mice by promoting the formation of protein lactylation. Theranostics, 14, 4297\u20134317.","journal-title":"Theranostics"},{"key":"11200_CR14","doi-asserted-by":"publisher","first-page":"e109890","DOI":"10.15252\/embj.2021109890","volume":"41","author":"HW Lee","year":"2022","unstructured":"Lee, H. W., Xu, Y., Zhu, X., et al. (2022). Endothelium-derived lactate is required for pericyte function and blood-brain barrier maintenance. Embo Journal, 41, e109890.","journal-title":"Embo Journal"},{"key":"11200_CR15","doi-asserted-by":"publisher","unstructured":"Narne, P., & Phanithi, P. B. (2023). Role of NAD+ and FAD in ischemic stroke pathophysiology: an epigenetic nexus and expanding therapeutic repertoire. Cellular And Molecular Neurobiology, 43. https:\/\/doi.org\/10.1007\/s10571-022-01287-4","DOI":"10.1007\/s10571-022-01287-4"},{"key":"11200_CR16","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.7150\/thno.25674","volume":"8","author":"S Jiang","year":"2018","unstructured":"Jiang, S., Li, T., Ji, T., et al. (2018). AMPK: potential therapeutic target for ischemic stroke. Theranostics, 8, 4535\u20134551.","journal-title":"Theranostics"},{"key":"11200_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/0271678X241261946","volume":"45","author":"M Roth","year":"2025","unstructured":"Roth, M., Carlsson, R., Buizza, C., Enstrom, A., & Paul-Visse, G. (2025). Pericyte response to ischemic stroke precedes endothelial cell death and blood-brain barrier breakdown. Journal Of Cerebral Blood Flow And Metabolism, 45, 617\u2013629.","journal-title":"Journal Of Cerebral Blood Flow And Metabolism"},{"key":"11200_CR18","doi-asserted-by":"publisher","first-page":"629297","DOI":"10.3389\/fnins.2021.629297","volume":"15","author":"L Cao","year":"2021","unstructured":"Cao, L., Zhou, Y., et al. (2021). Pericytes for therapeutic approaches to ischemic stroke. Front Neurosci, 15, 629297.","journal-title":"Front Neurosci"},{"key":"11200_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger, M. F., Discher, D. E., Peault, B. M., Phinney, D. G., Hare, J. M., & Caplan, A. I. (2019). Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med, 4, 22.","journal-title":"NPJ Regen Med"},{"key":"11200_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"AI Caplan","year":"2011","unstructured":"Caplan, A. I., & Correa, D. (2011). The MSC: an injury drugstore. Cell Stem Cell, 9, 11\u201315.","journal-title":"Cell Stem Cell"},{"key":"11200_CR21","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau, J., & Sensebe, L. (2018). Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell, 22, 824\u2013833.","journal-title":"Cell Stem Cell"},{"key":"11200_CR22","doi-asserted-by":"publisher","first-page":"641157","DOI":"10.3389\/fnins.2021.641157","volume":"15","author":"J He","year":"2021","unstructured":"He, J., Liu, J., Huang, Y., Tang, X., Xiao, H., & Hu, Z. (2021). Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cells-based therapies in ischemic stroke. Front Neurosci, 15, 641157.","journal-title":"Front Neurosci"},{"key":"11200_CR23","doi-asserted-by":"publisher","first-page":"628940","DOI":"10.3389\/fncel.2021.628940","volume":"15","author":"W Li","year":"2021","unstructured":"Li, W., Shi, L., Hu, B., et al. (2021). Mesenchymal stem cell-based therapy for stroke. Frontiers In Cellular Neuroscience, 15, 628940.","journal-title":"Frontiers In Cellular Neuroscience"},{"key":"11200_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13287-022-02876-2","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou, L., Lin, Q., Wang, P., et al. (2022). Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke. Stem Cell Research & Therapy, 13, 195.","journal-title":"Stem Cell Research & Therapy"},{"key":"11200_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-019-1571-8","volume":"16","author":"S Dabrowska","year":"2019","unstructured":"Dabrowska, S., Andrzejewska, A., Lukomska, B., & Janowski, M. (2019). Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation, 16, 178.","journal-title":"J Neuroinflammation"},{"key":"11200_CR26","doi-asserted-by":"publisher","first-page":"9923566","DOI":"10.1155\/2021\/9923566","volume":"2021","author":"Y Guo","year":"2021","unstructured":"Guo, Y., Peng, Y., Zeng, H., & Chen, G. (2021). Progress in mesenchymal stem cell therapy for ischemic stroke. Stem Cells Int, 2021, 9923566.","journal-title":"Stem Cells Int"},{"key":"11200_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","volume":"33","author":"H Xin","year":"2013","unstructured":"Xin, H., Li, Y., Cui, Y., Yang, J. J., Zhang, Z. G., & Chopp, M. (2013). Systemic administration of exosomes released from mesenchymal stromal cells promotes functional recovery and neurovascular plasticity after stroke in rats. Journal Of Cerebral Blood Flow And Metabolism, 33, 1711\u20131715.","journal-title":"Journal Of Cerebral Blood Flow And Metabolism"},{"key":"11200_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","volume":"4","author":"TR Doeppner","year":"2015","unstructured":"Doeppner, T. R., Herz, J., Gorgens, A., et al. (2015). Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med, 4, 1131\u20131143.","journal-title":"Stem Cells Transl Med"},{"key":"11200_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12975-017-0599-2","volume":"9","author":"RL Webb","year":"2018","unstructured":"Webb, R. L., Kaiser, E. E., Scoville, S. L., et al. (2018). Human neural stem cell extracellular vesicles improve tissue and functional recovery in the murine thromboembolic stroke model. Transl Stroke Res, 9, 530\u2013539.","journal-title":"Transl Stroke Res"},{"key":"11200_CR30","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A., Goberdhan, D. C. I., O\u2019Driscoll, L., et al. (2024). Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles, 13, e12404.","journal-title":"J Extracell Vesicles"},{"key":"11200_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature18928","volume":"535","author":"K Hayakawa","year":"2016","unstructured":"Hayakawa, K., Esposito, E., Wang, X., et al. (2016). Transfer of mitochondria from astrocytes to neurons after stroke. Nature, 535, 551\u2013555.","journal-title":"Nature"},{"key":"11200_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mvr.2019.01.001","volume":"123","author":"K Liu","year":"2019","unstructured":"Liu, K., Guo, L., Zhou, Z., Pan, M., & Yan, C. (2019). Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke. Microvascular Research, 123, 74\u201380.","journal-title":"Microvascular Research"},{"key":"11200_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0271678X20928147","volume":"41","author":"N Tseng","year":"2021","unstructured":"Tseng, N., Lambie, S. C., Huynh, C. Q., et al. (2021). Mitochondrial transfer from mesenchymal stem cells improves neuronal metabolism after oxidant injury in vitro: the role of Miro1. Journal Of Cerebral Blood Flow And Metabolism, 41, 761\u2013770.","journal-title":"Journal Of Cerebral Blood Flow And Metabolism"},{"key":"11200_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5483\/BMBRep.2022-0108","volume":"56","author":"EH Lee","year":"2023","unstructured":"Lee, E. H., Kim, M., Ko, S. H., Kim, C. H., Lee, M., & Park, C. H. (2023). Primary astrocytic mitochondrial transplantation ameliorates ischemic stroke. Bmb Reports, 56, 90\u201395.","journal-title":"Bmb Reports"},{"key":"11200_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/antiox12010178","volume":"12","author":"M Monsour","year":"2023","unstructured":"Monsour, M., Gordon, J., Lockard, G., Alayli, A., & Borlongan, C. V. (2023). Mitochondria in cell-based therapy for stroke. Antioxidants, 12, 178.","journal-title":"Antioxidants"},{"key":"11200_CR36","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","volume":"45","author":"K Prasad","year":"2014","unstructured":"Prasad, K., Sharma, A., Garg, A., et al. (2014). Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke, 45, 3618\u20133624.","journal-title":"Stroke"},{"key":"11200_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","volume":"16","author":"DC Hess","year":"2017","unstructured":"Hess, D. C., Wechsler, L. R., Clark, W. M., et al. (2017). Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurology, 16, 360\u2013368.","journal-title":"Lancet Neurology"},{"key":"11200_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/jamaneurol.2023.5200","volume":"81","author":"K Houkin","year":"2024","unstructured":"Houkin, K., Osanai, T., Uchiyama, S., et al. (2024). Allogeneic stem cell therapy for acute ischemic stroke: the phase 2\/3 TREASURE randomized clinical trial. JAMA Neurol, 81, 154\u2013162.","journal-title":"JAMA Neurol"},{"key":"11200_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/stcltm\/szad080","volume":"13","author":"DT Laskowitz","year":"2024","unstructured":"Laskowitz, D. T., et al. (2024). A randomized, placebo-controlled, phase II trial of intravenous allogeneic non-HLA matched, unrelated donor cord blood infusion for ischemic stroke. Stem Cells Transl Med, 13, 125\u2013136.","journal-title":"Stem Cells Transl Med"},{"key":"11200_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/sctm.18-0012","volume":"8","author":"J Fang","year":"2019","unstructured":"Fang, J., Guo, Y., Tan, S., et al. (2019). Autologous endothelial progenitor cells transplantation for acute ischemic stroke: a 4-year follow-up study. Stem Cells Transl Med, 8, 14\u201321.","journal-title":"Stem Cells Transl Med"},{"key":"11200_CR41","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3171\/2018.5.JNS173147","volume":"131","author":"GK Steinberg","year":"2018","unstructured":"Steinberg, G. K., Kondziolka, D., Wechsler, L. R., et al. (2018). Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1\/2a study. Case Report Journal Of Neurosurgery, 131, 1462\u20131472.","journal-title":"Case Report Journal Of Neurosurgery"},{"key":"11200_CR42","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s12975-020-00787-z","volume":"11","author":"A Jaillard","year":"2020","unstructured":"Jaillard, A., Hommel, M., Moisan, A., et al. (2020). Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial. Transl Stroke Res, 11, 910\u2013923.","journal-title":"Transl Stroke Res"},{"key":"11200_CR43","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","volume":"96","author":"JW Chung","year":"2021","unstructured":"Chung, J. W., Chang, W. H., Bang, O. Y., et al. (2021). Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke. Neurology, 96, e1012\u2013e1023.","journal-title":"Neurology"},{"key":"11200_CR44","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.011","volume":"23","author":"E Diez-Tejedor","year":"2014","unstructured":"Diez-Tejedor, E., Gutierrez-Fernandez, M., Martinez-Sanchez, P., et al. (2014). Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment. Journal Of Stroke And Cerebrovascular Diseases : The Official Journal Of National Stroke Association, 23, 2694\u20132700.","journal-title":"Journal Of Stroke And Cerebrovascular Diseases : The Official Journal Of National Stroke Association"},{"key":"11200_CR45","doi-asserted-by":"publisher","first-page":"21214","DOI":"10.1038\/s41598-025-04405-6","volume":"15","author":"T Osanai","year":"2025","unstructured":"Osanai, T., Takamiya, S., Morii, Y., et al. (2025). Efficacy and safety of stem cell therapy for acute and subacute ischemic stroke: a systematic review and meta-analysis. Scientific Reports, 15, 21214.","journal-title":"Scientific Reports"},{"key":"11200_CR46","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/stcltm\/szae040","volume":"13","author":"Z Shen","year":"2024","unstructured":"Shen, Z., et al. (2024). Efficacy and safety of mesenchymal stem cell therapies for ischemic stroke: a systematic review and meta-analysis. Stem Cells Transl Med, 13, 886\u2013897.","journal-title":"Stem Cells Transl Med"},{"key":"11200_CR47","first-page":"CD007231","volume":"5","author":"GB Boncoraglio","year":"2019","unstructured":"Boncoraglio, G. B., Ranieri, M., Bersano, A., Parati, E. A., & Del Giovane, C. (2019). Stem cell transplantation for ischemic stroke. Cochrane Database Systematic Review, 5, CD007231.","journal-title":"Cochrane Database Systematic Review"},{"key":"11200_CR48","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCULATIONAHA.117.030659","volume":"139","author":"SI Savitz","year":"2019","unstructured":"Savitz, S. I., Yavagal, D., Rappard, G., et al. (2019). A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-Stroke). Circulation, 139, 192\u2013205.","journal-title":"Circulation"},{"key":"11200_CR49","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s12015-025-11047-8","volume":"22","author":"I Alipourfard","year":"2026","unstructured":"Alipourfard, I., Mokhtari, T., Lesniak, A., Saharkhiz, S., & Zelazewska, Z. (2026). Immunomodulatory agents and factors in poor hematopoietic stem cell mobilization: Current sterategies and future prospects. Stem Cell Rev and Rep, 22, 1127\u20131138.","journal-title":"Stem Cell Rev and Rep"},{"key":"11200_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12975-019-00736-5","volume":"11","author":"MM Lalu","year":"2020","unstructured":"Lalu, M. M., Montroy, J., Dowlatshahi, D., et al. (2020). From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke. Transl Stroke Res, 11, 345\u2013364.","journal-title":"Transl Stroke Res"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11200-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:03:55Z","timestamp":1788768235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11200-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11200"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11200-x","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"1 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human and animal subjects.","order":3,"name":"Ethics","label":"Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used ChatGPT in order to enhance the clarity, grammar, and flow of the writing and improve of illustrations. After using this service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","label":"Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}